Scientific output - Hemotherapy-Hemostasis - Research

Research

Impact factor: duration: 3.92, total: 58.86

Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus

Jimenez S, Tassies D, Espinosa G, Garcia-Criado A, Plaza J, Monteagudo J, Cervera R, Reverter JC
ANN RHEUM DIS. 2008; 67: 835-840. IF: 6.411
Functional characterization of twelve natural PROS1 mutations associated with anticoagulant protein S deficiency

Hurtado B, Munoz X, Mulero MC, Navarro G, Domenech P, DeFrutos PG, Perez-Riba M, Sala N
HAEMATOL-HEMATOL J. 2008; 93: 574-580. IF: 5.516
Genetic loss of Gas6 induces plaque stability in expeximental atherosclerosis

Lutgens E, Tjwa M, DeFrutos PG, Wijnands E, Beckers L, Dahlback B, Daemen MJAP, Carmeliet P, Moons L
J PATHOL. 2008; 216: 55-63. IF: 5.423
Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study

DelRio-Garma J, Alvarez-Larran A, Martinez C, Muncunill J, Castella D, DeLaRubia J, Zamora C, Corral M, Viejo A, Pena F, Rodriguez-Vicente P, Contreras E, Arbona C, Ramirez C, Garcia-Erce JA, Alegre A, Mateo J, Pereira A
BRIT J HAEMATOL. 2008; 143: 39-45. IF: 4.49
Differential expression of proteins from cultured endothelial cells exposed to uremic versus normal serum

Carbo C, Arderiu G, Escolar G, Fuste B, Cases A, Carrascal M, Abian J, Diaz-Ricart M
AM J KIDNEY DIS. 2008; 51: 603-612. IF: 3.981

Impact factor: duration: 3.7, total: 7.39

Vitamin K-dependent actions of Gas6

Bellido-Martin L, DeFrutos PG
VITAM HORM. 2008; 78: 185-209. IF: 3.889
Growth arrest-specific gene 6 (GAS6)

Fernandez-Fernandez L, Bellido-Martin L, DeFrutos PG
THROMB HAEMOSTASIS. 2008; 100: 604-610. IF: 3.501

Impact factor: duration: 4.39, total: 4.39

Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: Results from population-based surveillance of candidemia in Spain

Gomez-Lopez A, Alastruey-Izquierdo A, Rodriguez D, Almirante B, Pahissa A, Rodriguez-Tudela JL, Cuenca-Estrella A, Mensa J, Almela M, Reverter J, Soler C
ANTIMICROB AGENTS CH . 2008; 52: 1506-1509. IF: 4.39

Impact factor: duration: 6.12, total: 12.23

Platelets come back in from the cold

Lozano M
BLOOD. 2008; 111: 2951-2951. IF: 10.896
Bilateral suprarenal hematoma in a 46-year-old male

Carballeiraa MR, DeJuanb C, Reverter JC
MED CLIN-BARCELONA. 2008; 130: 71-77. IF: 1.337

Factor tisular, inflamación y sistema serotoninérgico: contribución a las complicaciones isquémicas mediadas por plaquetas.
Factors relacionats amb el manteniment de la inflamació i l'oclusió vascular . Implicacions en l'evolució dels pacients amb arteritis de cèl.lules gegants.

Irene López Vilchez,
Escolar G, Galan A

Mecanismos de activación plaquetar en la interacción leucocito-endotelio

Principal investigator : García P. Funding source: Ministerio Educación y Ciencia. Code: BFU-2007- 61699. Average: 12/01/2007 - 11/30/2010
Papel de GAS6 en patología humana: estudios usando modelos animales y celulares

Principal investigator : Pablo Garcia. Funding source: Ministerio Educación y Ciencia. Code: SAF2004-07539-CO2-01. Average: 12/13/2004 - 03/12/2008
Protección del endotelio vascular en la enfermedad renal crónica: inhibidores del factor de transcripción NF Kappa B y terapia antioxidante

Principal investigator : Diaz M. Funding source: Ministerio Sanidad y Consumo. Code: PI060260. Average: 10/18/2006 - 12/30/2009
Red HERACLES: Determinantes genéticos y ambientales de la disfunción vascular

Principal investigator : Escolar G. Funding source: INSTITUTO DE SALUD CARLOS III. Code: RD06/0009/1003. Average: 02/29/2008 - 12/31/2010
Eficacia de un tratamiento de rehabilitación cognitiva en adolescentes con trastornos del espectro de la esquizofrenia.

Principal investigator : Reverter JC. Funding source: INSTITUTO DE SALUD CARLOS III. Code: PI07/90054. Average: 01/31/2008 - 12/30/2009